Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

A 45-year-old female with a medical history of systemic lupus erythematosus presented with breast cancer. On postoperative day 26 after undergoing left mastectomy and axillary lymph node dissection, she reported fever and anorexia at the outpatient clinic. Laboratory findings showed pancytopenia, and a subsequent bone marrow biopsy confirmed metastatic breast cancer involving the bone marrow. Tamoxifen and goserelin therapy was started initially. However, on the day after treatment initiation, the patient experienced rapid progression of anemia, with laboratory evidence of hemolysis and clinical signs of jaundice and splenomegaly; this led to a diagnosis of autoimmune hemolytic anemia(AIHA). Steroid pulse therapy resulted in a dramatic halt in anemia progression. Given that AIHA is a paraneoplastic syndrome with suspected resistance to endocrine therapy, chemotherapy with paclitaxel was initiated. AIHA recurrence was not observed after this intervention. In cases of breast cancer with bone marrow metastasis and acute anemia, especially in patients with an autoimmune history, a differential diagnosis beyond marrow suppression from metastasis should be carefully considered.

Download full-text PDF

Source

Publication Analysis

Top Keywords

breast cancer
16
bone marrow
16
cancer bone
8
marrow metastasis
8
history systemic
8
systemic lupus
8
lupus erythematosus
8
autoimmune hemolytic
8
marrow
5
case breast
4

Similar Publications

Chemotherapeutic resistance is a significant issue in the treatment of breast cancer, which is related to pyroptosis inhibition. Increasing evidence suggests that long non-coding RNAs (lncRNAs) contribute to tumorigenesis and drug resistance. In this study we investigated the role of the lncRNA STMN1P2 in doxorubicin resistance in breast cancer, as well as its correlation with pyroptosis inhibition.

View Article and Find Full Text PDF

Comprehensive genomic profiling (CGP) expands treatment options for solid tumor patients and identifies hereditary cancers. However, in Japan, confirmatory tests have been conducted in only 31.6% of patients with presumed germline pathogenic variants (GPVs) detected through tumor-only testing.

View Article and Find Full Text PDF

Purpose: Recent advancements in medical technologies have made trans-arterial treatment of breast cancer feasible. Consequently, understanding the vascular anatomies of breast cancers and axillary lymph node metastases has become indispensable for sophisticated treatments. The aim of this study was to determine the vascular anatomy of the breast, which is crucial for trans-arterial chemoembolization in patients with breast cancer.

View Article and Find Full Text PDF